Latanoprost/Timolol Pharmathen

Timolol maleate and Latanoprost, the active ingredients in Latanoprost/Timolol Pharmathen, are a beta‑blocker and a prostaglandin analog presented as an ophthalmic solution for ocular use. They are indicated for the reduction of intra‑ocular pressure in glaucoma and ocular hypertension patients.

GNH USA supplies Latanoprost/Timolol Pharmathen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol Pharmathen is used in the management of ocular conditions that require lowering of intra‑ocular pressure.

Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers pressure to prevent conversion to glaucoma. Glaucoma (any type): provides combined mechanism to control pressure when monotherapy is insufficient.

Latanoprost/Timolol Pharmathen may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (red eye). - Darkening of the iris or peri‑ocular skin. - Increased eyelash growth. - Foreign body sensation.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Persistent eye pain or inflammation. - Sudden loss of vision. - Corneal ulceration or keratitis. - Systemic bradycardia or hypotension. - Respiratory distress in susceptible patients.

Before prescribing Latanoprost/Timolol Pharmathen, clinicians should consider patient‑specific factors.

Assess cardiac status: avoid in patients with severe bradycardia or heart block. Monitor respiratory disease: use with caution in asthma or COPD. Avoid in sinus node dysfunction: contraindicated in patients with sick sinus syndrome. Check for hypersensitivity: discontinue if allergic reactions occur. Evaluate systemic beta‑blocker use: consider additive effects on heart rate and blood pressure. Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost/Timolol Pharmathen can interact with other systemic or ocular agents.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: may cause excessive bradycardia or hypotension. - Other intra‑ocular pressure‑lowering agents (e.g., pilocarpine) used concurrently: risk of additive ocular effects. - Anti‑arrhythmic drugs (e.g., propranolol): increased risk of cardiac depression.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: monitor blood pressure for additive lowering. - Asthma or COPD treatments: watch for bronchospasm exacerbation. - NSAIDs or corticosteroid eye drops: may affect ocular surface tolerance. - MAO inhibitors: observe for potential cardiovascular changes.